Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/24/25 16:35 | 3/20/25 | KNSA | Health | Drug | Pharmaceutical Preparations | Ragosa Mark | X0 | O | CFO | 3 | S.dm | -1,648 | 22.68 | 0 | -73 | 23 | D | |||||||||||||||
3/14/25 16:38 | 3/12/25 | KNSA | Health | Drug | Pharmaceutical Preparations | Megna Michael R | X0 | O | CHIEF AC | 1 | S.d | -203 | 22.45 | 0 | -9 | 27 | D | |||||||||||||||
3/12/25 16:37 | 3/10/25 | KNSA | Health | Drug | Pharmaceutical Preparations | Tessari Eben | X0 | O | COO | 3 | S.d | -791 | 19.57 | 0 | -40 | 89 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |